Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rey-Joly

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Medicina Clinica|May 11, 1996
[Diagnostic approach to neoplasms at an internal medicine service]A Urrutia, A Segura, M Monreal, et al.
British Journal of Addiction|June 1, 1990
Natural history of parenteral drug addicts treated in a general hospitalR Muga, J Tor, C Ginesta, et al.
Medicina Clinica|April 7, 1984
[Enterobacter agglomerans bacteremia (Erwinia herbicola)]A Guarga, A Urrutia, R Muga, et al.
Current HIV Research|June 17, 2011
Estimated liver fibrosis and its impact on all-cause mortality of HCV-monoinfected and HCV/HIV-coinfected drug usersA Sanvisens, D Fuster, I Serra, et al.
Medicina Clinica|October 24, 1987
[Transitory monoclonal gammapathy and acute infection]M Sabriá Leal, M L Pedro-Botet Montoya, R Melió García, et al.
Revista Clinica Espanola|November 1, 1989
[Predictive value of neopterin in boutonneuse fever]V Soriano, M Sabriá, J Davins, et al.
Medicina Clinica|January 25, 1986
[Changes in cellular immunity in parenteral drug addicts]J Tor, J Juncá, R Muga, et al.
Medicina Clinica|January 27, 1996
[Rates of human immunodeficiency virus (HIV) infection in intravenous drug addicts from the Barcelona area, according to sex and age of drug consumption onset]J M Egea, J Tor, R Muga, et al.
Journal of Epidemiology and Community Health|March 18, 2004
Impact of injecting drug use on the interruption of antiretroviral therapiesR Muga, J M Egea, A Sanvisens, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 3, 2000
Mortality of HIV-positive and HIV-negative heroin abusers as a function of duration of injecting drug useR Muga, J Roca, J M Egea, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Medicina Clinica|May 11, 1996
[Diagnostic approach to neoplasms at an internal medicine service]A Urrutia, A Segura, M Monreal, et al.
British Journal of Addiction|June 1, 1990
Natural history of parenteral drug addicts treated in a general hospitalR Muga, J Tor, C Ginesta, et al.
Medicina Clinica|April 7, 1984
[Enterobacter agglomerans bacteremia (Erwinia herbicola)]A Guarga, A Urrutia, R Muga, et al.
Current HIV Research|June 17, 2011
Estimated liver fibrosis and its impact on all-cause mortality of HCV-monoinfected and HCV/HIV-coinfected drug usersA Sanvisens, D Fuster, I Serra, et al.
Medicina Clinica|October 24, 1987
[Transitory monoclonal gammapathy and acute infection]M Sabriá Leal, M L Pedro-Botet Montoya, R Melió García, et al.
Revista Clinica Espanola|November 1, 1989
[Predictive value of neopterin in boutonneuse fever]V Soriano, M Sabriá, J Davins, et al.
Medicina Clinica|January 25, 1986
[Changes in cellular immunity in parenteral drug addicts]J Tor, J Juncá, R Muga, et al.
Medicina Clinica|January 27, 1996
[Rates of human immunodeficiency virus (HIV) infection in intravenous drug addicts from the Barcelona area, according to sex and age of drug consumption onset]J M Egea, J Tor, R Muga, et al.
Journal of Epidemiology and Community Health|March 18, 2004
Impact of injecting drug use on the interruption of antiretroviral therapiesR Muga, J M Egea, A Sanvisens, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 3, 2000
Mortality of HIV-positive and HIV-negative heroin abusers as a function of duration of injecting drug useR Muga, J Roca, J M Egea, et al.
Pageof 9